News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lochner Daniel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/04/2023 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Paid exercise price by delivering 938 shares
@ $11.7, valued at
$11k
Unknown transaction of 56,289 shares
@ $0
Disposed/sold 20,236 shares
@ $0
Disposed/sold 300,000 rights
@ $0
Disposed/sold 161,251 options to buy
@ $11.51, valued at
$1.9M
Disposed/sold 72,648 options to buy
@ $32.65, valued at
$2.4M
Disposed/sold 50,500 options to buy
@ $18.77, valued at
$947.9k
Disposed/sold 45,000 options to buy
@ $13.78, valued at
$620.1k
Disposed/sold 87,900 options to buy
@ $16, valued at
$1.4M
|
|
| 12/06/2022 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Paid exercise price by delivering 3,258 shares
@ $11.2, valued at
$36.5k
|
|
| 07/08/2022 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Granted 300,000 rights
@ $0 |
|
| 01/11/2022 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Granted 19,500 shares
@ $0
Granted 87,900 options to buy
@ $16, valued at
$1.4M
|
|
| 11/02/2021 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Exercised 8,590 options to buy
@ $11.51, valued at
$98.9k
|
|
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2020 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Exercised 4,000 options to buy
@ $11.51, valued at
$46k
|
|
| 08/18/2020 |
4/A
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Exercised 4,000 shares
@ $11.51, valued at
$46k
|
|
| 08/12/2020 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Exercised 4,000 options to buy
@ $11.51, valued at
$46k
|
|
| 02/05/2020 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Granted 72,648 options to buy
@ $32.65, valued at
$2.4M
|
|
| 11/05/2019 |
4
| Lochner Daniel (CFO) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Bought 6,300 shares
@ $16, valued at
$100.8k
|
|
| 10/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|